Patients receiving a prescription for diamorphine (heroin) in the United Kingdom

The United Kingdom is unusual internationally in that it is one of few countries able to prescribe diamorphine for the treatment of opiate dependence. Prescribing diamorphine has been part of the UK response to drug problems since the 1920s. Despite this, little is known about who receives diamorphi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug and alcohol review 2006-03, Vol.25 (2), p.115-121
Hauptverfasser: Metrebian, N., Carnwath, Z., Mott, J., Carnwath, T., Stimson, G. V., Sell, L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 121
container_issue 2
container_start_page 115
container_title Drug and alcohol review
container_volume 25
creator Metrebian, N.
Carnwath, Z.
Mott, J.
Carnwath, T.
Stimson, G. V.
Sell, L.
description The United Kingdom is unusual internationally in that it is one of few countries able to prescribe diamorphine for the treatment of opiate dependence. Prescribing diamorphine has been part of the UK response to drug problems since the 1920s. Despite this, little is known about who receives diamorphine and how treatment is delivered. This study aims to describe the characteristics and treatment regimes of opiate-dependent drug users receiving a prescription for diamorphine in the United Kingdom in 2000, and report on their status in 2002. A retrospective case-note review was conducted in England and Wales. Two hundred and ten (72%; 210 292) patients' sets of case-notes were reviewed at 27 of the 42 (64%) drug clinics where diamorphine was prescribed by the doctor. Patients had been receiving a prescription for diamorphine for a median length of six years. The majority were unemployed white males, with a median age of 44 years. Illicit drug use and criminal activity, while low, had not been eliminated totally. The majority were prescribed ampoules and few had significant health problems. In some cases patients had been transferred to injectable diamorphine from injectable methadone to reduce injection related problems. There were wide variations in dose. The majority of patients had no serious drug, health or social problems. Diamorphine prescribing was a long-term commitment. The experience from the United Kingdom has been one of long-term prescribing with the aim of retaining patients in treatment and reducing the harms caused by illicit drug use. Prospective studies are needed to determine the long-term consequences of receiving a diamorphine prescription. [Metrebian N, Carnwath Z, Mott J, Carnwath T, Stimson GV, Sell L. Patients receiving a prescription for diamorphine (heroin) in the United Kingdom. Drug Alcohol Rev 2006;25:115 - 121]
doi_str_mv 10.1080/09595230500537175
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_57191238</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>57191238</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4669-7fb9c804029520f59a927bb1e3d4301057da4646534f8422720a5ab1140effd33</originalsourceid><addsrcrecordid>eNqFkcFu1DAURS0EokPhA9ggrxBdBJ7t2E7EqiqlIEYwQq2QZmM5yQtxSezUzgD9e1zNCBZIsPLC51zp3kfIUwYvGVTwCmpZSy5AAkihmZb3yIqVShZCKH6frO7-iwyoI_IopWsA4FLyh-SIKcW1AFiRzcYuDv2SaMQW3Xfnv1JL54ipjW5eXPC0D5F2zk4hzoPzSF8MGIPzJ9R5ugxIr7xbsKMfstqF6TF50Nsx4ZPDe0yu3p5fnr0r1p8u3p-drou2VKoudN_UbQUl8NwAelnbmuumYSi6UgADqTtbqtxFlH1Vcq45WGkbxkrAvu-EOCbP97lzDDc7TIuZXGpxHK3HsEtGalYzLqoMsj3YxpBSxN7M0U023hoG5m5G89eM2Xl2CN81E3Z_jMNuGZB74Icb8fb_iebN6WfN6-wVe8-lBX_-9mz8ZpQWmfvy8cJs11V5KTZbs8386wPv8xkmO6Adl6G1Ec112EWfF_5HjV-bxJxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>57191238</pqid></control><display><type>article</type><title>Patients receiving a prescription for diamorphine (heroin) in the United Kingdom</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Taylor &amp; Francis:Master (3349 titles)</source><creator>Metrebian, N. ; Carnwath, Z. ; Mott, J. ; Carnwath, T. ; Stimson, G. V. ; Sell, L.</creator><creatorcontrib>Metrebian, N. ; Carnwath, Z. ; Mott, J. ; Carnwath, T. ; Stimson, G. V. ; Sell, L.</creatorcontrib><description>The United Kingdom is unusual internationally in that it is one of few countries able to prescribe diamorphine for the treatment of opiate dependence. Prescribing diamorphine has been part of the UK response to drug problems since the 1920s. Despite this, little is known about who receives diamorphine and how treatment is delivered. This study aims to describe the characteristics and treatment regimes of opiate-dependent drug users receiving a prescription for diamorphine in the United Kingdom in 2000, and report on their status in 2002. A retrospective case-note review was conducted in England and Wales. Two hundred and ten (72%; 210 292) patients' sets of case-notes were reviewed at 27 of the 42 (64%) drug clinics where diamorphine was prescribed by the doctor. Patients had been receiving a prescription for diamorphine for a median length of six years. The majority were unemployed white males, with a median age of 44 years. Illicit drug use and criminal activity, while low, had not been eliminated totally. The majority were prescribed ampoules and few had significant health problems. In some cases patients had been transferred to injectable diamorphine from injectable methadone to reduce injection related problems. There were wide variations in dose. The majority of patients had no serious drug, health or social problems. Diamorphine prescribing was a long-term commitment. The experience from the United Kingdom has been one of long-term prescribing with the aim of retaining patients in treatment and reducing the harms caused by illicit drug use. Prospective studies are needed to determine the long-term consequences of receiving a diamorphine prescription. [Metrebian N, Carnwath Z, Mott J, Carnwath T, Stimson GV, Sell L. Patients receiving a prescription for diamorphine (heroin) in the United Kingdom. Drug Alcohol Rev 2006;25:115 - 121]</description><identifier>ISSN: 0959-5236</identifier><identifier>EISSN: 1465-3362</identifier><identifier>DOI: 10.1080/09595230500537175</identifier><identifier>PMID: 16627300</identifier><language>eng</language><publisher>Oxford, UK: Informa UK Ltd</publisher><subject>Ambulatory Care Facilities ; Crime ; diamorphine ; England - epidemiology ; Health Status ; Heroin ; Heroin - administration &amp; dosage ; Heroin Dependence - rehabilitation ; Humans ; Mental Disorders - epidemiology ; Narcotics - administration &amp; dosage ; opiate dependence treatment ; Opiates ; Practice Patterns, Physicians ; Retrospective Studies ; Substance dependency ; United Kingdom ; Wales - epidemiology</subject><ispartof>Drug and alcohol review, 2006-03, Vol.25 (2), p.115-121</ispartof><rights>2006 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2006</rights><rights>2006 Australasian Professional Society on Alcohol and other Drugs</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4669-7fb9c804029520f59a927bb1e3d4301057da4646534f8422720a5ab1140effd33</citedby><cites>FETCH-LOGICAL-c4669-7fb9c804029520f59a927bb1e3d4301057da4646534f8422720a5ab1140effd33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/09595230500537175$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/09595230500537175$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,31005,45579,45580,61226,61407</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16627300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Metrebian, N.</creatorcontrib><creatorcontrib>Carnwath, Z.</creatorcontrib><creatorcontrib>Mott, J.</creatorcontrib><creatorcontrib>Carnwath, T.</creatorcontrib><creatorcontrib>Stimson, G. V.</creatorcontrib><creatorcontrib>Sell, L.</creatorcontrib><title>Patients receiving a prescription for diamorphine (heroin) in the United Kingdom</title><title>Drug and alcohol review</title><addtitle>Drug Alcohol Rev</addtitle><description>The United Kingdom is unusual internationally in that it is one of few countries able to prescribe diamorphine for the treatment of opiate dependence. Prescribing diamorphine has been part of the UK response to drug problems since the 1920s. Despite this, little is known about who receives diamorphine and how treatment is delivered. This study aims to describe the characteristics and treatment regimes of opiate-dependent drug users receiving a prescription for diamorphine in the United Kingdom in 2000, and report on their status in 2002. A retrospective case-note review was conducted in England and Wales. Two hundred and ten (72%; 210 292) patients' sets of case-notes were reviewed at 27 of the 42 (64%) drug clinics where diamorphine was prescribed by the doctor. Patients had been receiving a prescription for diamorphine for a median length of six years. The majority were unemployed white males, with a median age of 44 years. Illicit drug use and criminal activity, while low, had not been eliminated totally. The majority were prescribed ampoules and few had significant health problems. In some cases patients had been transferred to injectable diamorphine from injectable methadone to reduce injection related problems. There were wide variations in dose. The majority of patients had no serious drug, health or social problems. Diamorphine prescribing was a long-term commitment. The experience from the United Kingdom has been one of long-term prescribing with the aim of retaining patients in treatment and reducing the harms caused by illicit drug use. Prospective studies are needed to determine the long-term consequences of receiving a diamorphine prescription. [Metrebian N, Carnwath Z, Mott J, Carnwath T, Stimson GV, Sell L. Patients receiving a prescription for diamorphine (heroin) in the United Kingdom. Drug Alcohol Rev 2006;25:115 - 121]</description><subject>Ambulatory Care Facilities</subject><subject>Crime</subject><subject>diamorphine</subject><subject>England - epidemiology</subject><subject>Health Status</subject><subject>Heroin</subject><subject>Heroin - administration &amp; dosage</subject><subject>Heroin Dependence - rehabilitation</subject><subject>Humans</subject><subject>Mental Disorders - epidemiology</subject><subject>Narcotics - administration &amp; dosage</subject><subject>opiate dependence treatment</subject><subject>Opiates</subject><subject>Practice Patterns, Physicians</subject><subject>Retrospective Studies</subject><subject>Substance dependency</subject><subject>United Kingdom</subject><subject>Wales - epidemiology</subject><issn>0959-5236</issn><issn>1465-3362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqFkcFu1DAURS0EokPhA9ggrxBdBJ7t2E7EqiqlIEYwQq2QZmM5yQtxSezUzgD9e1zNCBZIsPLC51zp3kfIUwYvGVTwCmpZSy5AAkihmZb3yIqVShZCKH6frO7-iwyoI_IopWsA4FLyh-SIKcW1AFiRzcYuDv2SaMQW3Xfnv1JL54ipjW5eXPC0D5F2zk4hzoPzSF8MGIPzJ9R5ugxIr7xbsKMfstqF6TF50Nsx4ZPDe0yu3p5fnr0r1p8u3p-drou2VKoudN_UbQUl8NwAelnbmuumYSi6UgADqTtbqtxFlH1Vcq45WGkbxkrAvu-EOCbP97lzDDc7TIuZXGpxHK3HsEtGalYzLqoMsj3YxpBSxN7M0U023hoG5m5G89eM2Xl2CN81E3Z_jMNuGZB74Icb8fb_iebN6WfN6-wVe8-lBX_-9mz8ZpQWmfvy8cJs11V5KTZbs8386wPv8xkmO6Adl6G1Ec112EWfF_5HjV-bxJxg</recordid><startdate>200603</startdate><enddate>200603</enddate><creator>Metrebian, N.</creator><creator>Carnwath, Z.</creator><creator>Mott, J.</creator><creator>Carnwath, T.</creator><creator>Stimson, G. V.</creator><creator>Sell, L.</creator><general>Informa UK Ltd</general><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope></search><sort><creationdate>200603</creationdate><title>Patients receiving a prescription for diamorphine (heroin) in the United Kingdom</title><author>Metrebian, N. ; Carnwath, Z. ; Mott, J. ; Carnwath, T. ; Stimson, G. V. ; Sell, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4669-7fb9c804029520f59a927bb1e3d4301057da4646534f8422720a5ab1140effd33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Ambulatory Care Facilities</topic><topic>Crime</topic><topic>diamorphine</topic><topic>England - epidemiology</topic><topic>Health Status</topic><topic>Heroin</topic><topic>Heroin - administration &amp; dosage</topic><topic>Heroin Dependence - rehabilitation</topic><topic>Humans</topic><topic>Mental Disorders - epidemiology</topic><topic>Narcotics - administration &amp; dosage</topic><topic>opiate dependence treatment</topic><topic>Opiates</topic><topic>Practice Patterns, Physicians</topic><topic>Retrospective Studies</topic><topic>Substance dependency</topic><topic>United Kingdom</topic><topic>Wales - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Metrebian, N.</creatorcontrib><creatorcontrib>Carnwath, Z.</creatorcontrib><creatorcontrib>Mott, J.</creatorcontrib><creatorcontrib>Carnwath, T.</creatorcontrib><creatorcontrib>Stimson, G. V.</creatorcontrib><creatorcontrib>Sell, L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><jtitle>Drug and alcohol review</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Metrebian, N.</au><au>Carnwath, Z.</au><au>Mott, J.</au><au>Carnwath, T.</au><au>Stimson, G. V.</au><au>Sell, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patients receiving a prescription for diamorphine (heroin) in the United Kingdom</atitle><jtitle>Drug and alcohol review</jtitle><addtitle>Drug Alcohol Rev</addtitle><date>2006-03</date><risdate>2006</risdate><volume>25</volume><issue>2</issue><spage>115</spage><epage>121</epage><pages>115-121</pages><issn>0959-5236</issn><eissn>1465-3362</eissn><abstract>The United Kingdom is unusual internationally in that it is one of few countries able to prescribe diamorphine for the treatment of opiate dependence. Prescribing diamorphine has been part of the UK response to drug problems since the 1920s. Despite this, little is known about who receives diamorphine and how treatment is delivered. This study aims to describe the characteristics and treatment regimes of opiate-dependent drug users receiving a prescription for diamorphine in the United Kingdom in 2000, and report on their status in 2002. A retrospective case-note review was conducted in England and Wales. Two hundred and ten (72%; 210 292) patients' sets of case-notes were reviewed at 27 of the 42 (64%) drug clinics where diamorphine was prescribed by the doctor. Patients had been receiving a prescription for diamorphine for a median length of six years. The majority were unemployed white males, with a median age of 44 years. Illicit drug use and criminal activity, while low, had not been eliminated totally. The majority were prescribed ampoules and few had significant health problems. In some cases patients had been transferred to injectable diamorphine from injectable methadone to reduce injection related problems. There were wide variations in dose. The majority of patients had no serious drug, health or social problems. Diamorphine prescribing was a long-term commitment. The experience from the United Kingdom has been one of long-term prescribing with the aim of retaining patients in treatment and reducing the harms caused by illicit drug use. Prospective studies are needed to determine the long-term consequences of receiving a diamorphine prescription. [Metrebian N, Carnwath Z, Mott J, Carnwath T, Stimson GV, Sell L. Patients receiving a prescription for diamorphine (heroin) in the United Kingdom. Drug Alcohol Rev 2006;25:115 - 121]</abstract><cop>Oxford, UK</cop><pub>Informa UK Ltd</pub><pmid>16627300</pmid><doi>10.1080/09595230500537175</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0959-5236
ispartof Drug and alcohol review, 2006-03, Vol.25 (2), p.115-121
issn 0959-5236
1465-3362
language eng
recordid cdi_proquest_miscellaneous_57191238
source MEDLINE; Access via Wiley Online Library; Applied Social Sciences Index & Abstracts (ASSIA); Taylor & Francis:Master (3349 titles)
subjects Ambulatory Care Facilities
Crime
diamorphine
England - epidemiology
Health Status
Heroin
Heroin - administration & dosage
Heroin Dependence - rehabilitation
Humans
Mental Disorders - epidemiology
Narcotics - administration & dosage
opiate dependence treatment
Opiates
Practice Patterns, Physicians
Retrospective Studies
Substance dependency
United Kingdom
Wales - epidemiology
title Patients receiving a prescription for diamorphine (heroin) in the United Kingdom
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T06%3A19%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patients%20receiving%20a%20prescription%20for%20diamorphine%20(heroin)%20in%20the%20United%20Kingdom&rft.jtitle=Drug%20and%20alcohol%20review&rft.au=Metrebian,%20N.&rft.date=2006-03&rft.volume=25&rft.issue=2&rft.spage=115&rft.epage=121&rft.pages=115-121&rft.issn=0959-5236&rft.eissn=1465-3362&rft_id=info:doi/10.1080/09595230500537175&rft_dat=%3Cproquest_cross%3E57191238%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=57191238&rft_id=info:pmid/16627300&rfr_iscdi=true